CD47 and neoplasm: AMG 510 treatment for 8 days significantly suppressed tumor growth, inhibited KRAS activity, STAT3 phosphorylation, and CD47 expression, and stimulated miR-34a expression in tumor tissues (Figure 9, A–E, and Supplemental Figure 16, A–E).